<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209284</url>
  </required_header>
  <id_info>
    <org_study_id>SLSS_IPA</org_study_id>
    <nct_id>NCT03209284</nct_id>
  </id_info>
  <brief_title>Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures</brief_title>
  <acronym>SLSS</acronym>
  <official_title>Influence of the Anatomical Variability of the Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Piezosurgery Academy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Triste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Piezosurgery Academy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyze neoformed bone after maxillary sinus lifting with&#xD;
      transcrestal approach, in atrophic crests (≤5 mm residual bone height). Clinical and&#xD;
      laboratory data will be related to maxillo breast anatomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone resorption and sinus pneumatization, following tooth extraction, are common occurrences&#xD;
      in the posterior maxilla. They may cause both a quantitative reduction and qualitative&#xD;
      deterioration of bone, resulting in an inadequate bone volume for a standard implant&#xD;
      placement. Sinus floor elevation with lateral approach had been described 35 years ago and&#xD;
      widely studied afterwards, demonstrating an high predictability in regenerating bone, to&#xD;
      allow for reliable implant supported rehabilitations. Maxillary sinus floor elevation with&#xD;
      transcrestal approach represents a validated and effective alternative option to vertically&#xD;
      enhance the available bone through an access created in the edentulous bone crest. Regardless&#xD;
      of graft type, it is not yet well defined how three-dimensional anatomical sinus cavity&#xD;
      characteristics may influence healing and mineralization process. An adequate Schneiderian&#xD;
      membrane elevation in order to expose sinus floor, buccal and medial walls, seems to&#xD;
      represent a crucial factor in influencing new bone formation, as the greatest part of the&#xD;
      osteoprogenitor cells derives from these anatomical structures. It is not documented yet the&#xD;
      efficacy of the different trnanscrestal sinus floor elevation approaches in exposing the&#xD;
      internal bony walls of the sinus. Moreover, on the basis of the fact that only few articles&#xD;
      correlated the size of the maxillary sinus with histologic outcome by lateral window and one&#xD;
      retrospective radiographic study reported results in relation to the three-dimensional&#xD;
      conformation of the sinus using a trans-crestal approach, the investigators conjecture that&#xD;
      sinus bucco-palatal diameter could influence the newly-formed bone quality after a crestal&#xD;
      sinus lift procedure. For example, the healing in a narrow maxillary sinus could result in a&#xD;
      faster new bone formation, when compared to a larger and wider sinus. The aim of this study&#xD;
      is to analyze neoformed bone after maxillary sinus lifting with transcrestal approach, in&#xD;
      atrophic crests (≤5 mm residual bone height). Clinical and laboratory data will be related to&#xD;
      maxillo breast anatomy. The present study has been designed as a multicenter prospective&#xD;
      clinical trial. Five clinical centers will treat patients with two-stage transcrestal sinus&#xD;
      floor elevation using a calibrated drills technique and a xenogeneic biomaterial. Implants&#xD;
      will be inserted 6 months after sinus augmentation and bone-core biopsies will be harvested&#xD;
      during the implant site preparation. Histological analyses will be performed in order to&#xD;
      assess the quality of the newly-formed tissue and cone beam computed tomography scan&#xD;
      examination will be used to evaluate graft resorption over time. For each inserted implant,&#xD;
      collection of experimental parameters will be required up to 1 year after its placement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2014</start_date>
  <completion_date type="Actual">February 15, 2017</completion_date>
  <primary_completion_date type="Actual">September 15, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>newly formed bone</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>assessment of newly formed bone via histomorphometric analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implant success</measure>
    <time_frame>1 years after implant insertion</time_frame>
    <description>short term implant success rate via clinical and radiographic data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exposed walls</measure>
    <time_frame>10 day after surgery</time_frame>
    <description>number of sinuses exposed walls after augmentation procedure via cone beam computed tomography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Atrophy of Edentulous Maxillary Alveolar Ridge</condition>
  <arm_group>
    <arm_group_label>narrow sinuses</arm_group_label>
    <description>transcrestal sinus floor elevation in narrow sinuses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>wide sinuses</arm_group_label>
    <description>transcrestal sinus floor elevation in wide sinuses</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transcrestal sinus floor elevation</intervention_name>
    <description>augmentation procedure with xenograft</description>
    <arm_group_label>narrow sinuses</arm_group_label>
    <arm_group_label>wide sinuses</arm_group_label>
    <other_name>implant insertion</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bone biopsies were retrieved at the time of implant placement (after 6 months of regenerative&#xD;
      procedure) and obtained through implant site preparation with trephine bur&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population was composed of all patients presenting for evaluation and management&#xD;
        of any partial edentulism requiring unilateral maxillary sinus elevation. To be included in&#xD;
        the study sample, patients had to present a residual crestal height on the sinus floor less&#xD;
        than 5 mm, to be 18 years or older, and able to understand and sign a written informed&#xD;
        consent form.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Local inclusion criteria will be the following:&#xD;
&#xD;
          -  indications for a transcrestal sinus floor augmentation to allow for a single implant&#xD;
             placement, based on accurate diagnosis and treatment planning;&#xD;
&#xD;
          -  presence of a residual bone crest with a height ≤3 mm on the maxillary sinus in the&#xD;
             site where implant placement is programmed;&#xD;
&#xD;
          -  the bone crest must be healed (at least three months elapsed after tooth loss);&#xD;
&#xD;
          -  age of the patient &gt;18 years;&#xD;
&#xD;
          -  patient willing and fully capable to comply with the study protocol;&#xD;
&#xD;
          -  written informed consent given.&#xD;
&#xD;
        General exclusion criteria are:&#xD;
&#xD;
          -  acute myocardial infarction within the past 2 months;&#xD;
&#xD;
          -  uncontrolled coagulation disorders;&#xD;
&#xD;
          -  uncontrolled diabetes (HBA1c &gt; 7.5%);&#xD;
&#xD;
          -  radiotherapy to the head/neck district within the past 24 months;&#xD;
&#xD;
          -  immunocompromised patient (HIV infection or chemotherapy within the past 5 years);&#xD;
&#xD;
          -  present or past treatment with intravenous bisphosphonates;&#xD;
&#xD;
          -  psychological or psychiatric problems;&#xD;
&#xD;
          -  alcohol or drugs abuse.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Local exclusion criterion is the presence of uncontrolled or untreated periodontal&#xD;
             disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Claudio Stacchi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piezosurgery Academy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Piezosurgery Academy</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Farina R, Pramstraller M, Franceschetti G, Pramstraller C, Trombelli L. Alveolar ridge dimensions in maxillary posterior sextants: a retrospective comparative study of dentate and edentulous sites using computerized tomography data. Clin Oral Implants Res. 2011 Oct;22(10):1138-1144. doi: 10.1111/j.1600-0501.2010.02087.x. Epub 2011 Feb 15.</citation>
    <PMID>21320169</PMID>
  </reference>
  <reference>
    <citation>Esposito M, Grusovin MG, Rees J, Karasoulos D, Felice P, Alissa R, Worthington H, Coulthard P. Effectiveness of sinus lift procedures for dental implant rehabilitation: a Cochrane systematic review. Eur J Oral Implantol. 2010 Spring;3(1):7-26. Review.</citation>
    <PMID>20467595</PMID>
  </reference>
  <reference>
    <citation>Avila G, Wang HL, Galindo-Moreno P, Misch CE, Bagramian RA, Rudek I, Benavides E, Moreno-Riestra I, Braun T, Neiva R. The influence of the bucco-palatal distance on sinus augmentation outcomes. J Periodontol. 2010 Jul;81(7):1041-50. doi: 10.1902/jop.2010.090686.</citation>
    <PMID>20450402</PMID>
  </reference>
  <results_reference>
    <citation>Lombardi T, Stacchi C, Berton F, Traini T, Torelli L, Di Lenarda R. Influence of Maxillary Sinus Width on New Bone Formation After Transcrestal Sinus Floor Elevation: A Proof-of-Concept Prospective Cohort Study. Implant Dent. 2017 Apr;26(2):209-216. doi: 10.1097/ID.0000000000000554.</citation>
    <PMID>28125520</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>International Piezosurgery Academy</investigator_affiliation>
    <investigator_full_name>Mr. Claudio Stacchi, DDS, MSc</investigator_full_name>
    <investigator_title>DDS, MSc</investigator_title>
  </responsible_party>
  <keyword>maxillary atrophy</keyword>
  <keyword>transcrestal sinus floor elevation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

